SHP-2 phosphatase is required for hematopoietic cell transformation by Bcr-Abl
Jing Chen(Heilongjiang University of Chinese Medicine), Cheng‐Kui Qu(Emory University)
Cited by 43
Related Papers
Effective and selective targeting of leukemia cells using a TORC1/2 kinase inhibitor
|Nature Medicine|2010|338
Non–lineage/stage-restricted effects of a gain-of-function mutation in tyrosine phosphatase <i>Ptpn11</i> (Shp2) on malignant transformation of hematopoietic cells
|The Journal of Experimental Medicine|2011|111
Discovery of Dual Inhibitors of MDM2 and XIAP for Cancer Treatment
|Cancer Cell|2016|85
Effects of a Leukemia-associated Gain-of-Function Mutation of SHP-2 Phosphatase on Interleukin-3 Signaling
|Journal of Biological Chemistry|2005|50
Noonan Syndrome/Leukemia-associated Gain-of-function Mutations in SHP-2 Phosphatase (PTPN11) Enhance Cell Migration and Angiogenesis
|Journal of Biological Chemistry|2008|37